相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Selective inhibition of Cx43 hemichannels by Gap19 and its impact on myocardial ischemia/reperfusion injury
Nan Wang et al.
BASIC RESEARCH IN CARDIOLOGY (2013)
Cardioprotection: chances and challenges of its translation to the clinic
Gerd Heusch
LANCET (2013)
Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol - a clinical trial
E. Kottenberg et al.
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2012)
Connexin mimetic peptides inhibit Cx43 hemichannel opening triggered by voltage and intracellular Ca2+ elevation
Nan Wang et al.
BASIC RESEARCH IN CARDIOLOGY (2012)
Trials, tribulations and speculation! Report from the 7th Biennial Hatter Cardiovascular Institute Workshop
Robert Bell et al.
BASIC RESEARCH IN CARDIOLOGY (2012)
STAT5 Activation and Cardioprotection by Remote Ischemic Preconditioning in Humans
Gerd Heusch et al.
CIRCULATION RESEARCH (2012)
Pre- and early in-hospital procedures in patients with acute coronary syndromes: first results of the German chest pain unit registry
Felix Post et al.
CLINICAL RESEARCH IN CARDIOLOGY (2012)
Reduction of infarct size by ischaemic post-conditioning in humans: fact or fiction?
Gerd Heusch
EUROPEAN HEART JOURNAL (2012)
Single intravenous low-dose injections of connexin 43 mimetic peptides protect ischemic heart in vivo against myocardial infarction
Ghayda Hawat et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2012)
Post-Conditioning Reduces Infarct Size and Edema in Patients With ST-Segment Elevation Myocardial Infarction
Franck Thuny et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Pharmacological modulation of connexin-formed channels in cardiac pathophysiology
Elke De Vuyst et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
New Horizons in Cardioprotection Recommendations From the 2010 National Heart, Lung, and Blood Institute Workshop
Lisa Schwartz Longacre et al.
CIRCULATION (2011)
Mitochondrial STAT3 Activation and Cardioprotection by Ischemic Postconditioning in Pigs With Regional Myocardial Ischemia/Reperfusion
Gerd Heusch et al.
CIRCULATION RESEARCH (2011)
The in-situ pig heart with regional ischemia/reperfusion - Ready for translation
Gerd Heusch et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2011)
Inhibition of mitochondrial permeability transition pore opening: the holy grail of cardioprotection
Gerd Heusch et al.
BASIC RESEARCH IN CARDIOLOGY (2010)
Remote ischemic preconditioning reduces myocardial injury after coronary artery bypass surgery with crystalloid cardioplegic arrest
Matthias Thielmann et al.
BASIC RESEARCH IN CARDIOLOGY (2010)
Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations
Derek J. Hausenloy et al.
BASIC RESEARCH IN CARDIOLOGY (2010)
Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion
Kerstin Boengler et al.
BASIC RESEARCH IN CARDIOLOGY (2010)
Cyclosporine A at Reperfusion Reduces Infarct Size in Pigs
Andreas Skyschally et al.
CARDIOVASCULAR DRUGS AND THERAPY (2010)
Postconditioning and protection from reperfusion injury: where do we stand?Position Paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology
Michel Ovize et al.
CARDIOVASCULAR RESEARCH (2010)
Presence of connexin 43 in subsarcolemmal, but not in interfibrillar cardiomyocyte mitochondria
Kerstin Boengler et al.
BASIC RESEARCH IN CARDIOLOGY (2009)
Ischemic postconditioning: experimental models and protocol algorithms
Andreas Skyschally et al.
BASIC RESEARCH IN CARDIOLOGY (2009)
Connexin43 phosphorylation: structural changes and biological effects
Joell L. Solan et al.
BIOCHEMICAL JOURNAL (2009)
Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway
Lydia Lacerda et al.
CARDIOVASCULAR RESEARCH (2009)
Human cardiac gap-junction coupling: effects of antiarrhythmic peptide AAP10
Anja Hagen et al.
CARDIOVASCULAR RESEARCH (2009)
Ischemic Postconditioning in Pigs No Causal Role for RISK Activation
Andreas Skyschally et al.
CIRCULATION RESEARCH (2009)
Effects of Chronic Gap Junction Conduction-Enhancing Antiarrhythmic Peptide GAP-134 Administration on Experimental Atrial Fibrillation in Dogs
Gabriel Laurent et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2009)
GAP-134 ([2S,4R]-1-[2-Aminoacetyl]-4-Benzamidopyrrolidine-2-Carboxylic Acid) Prevents Spontaneous Ventricular Arrhythmias and Reduces Infarct Size During Myocardial Ischemia/Reperfusion Injury in Open-Chest Dogs
James K. Hennan et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2009)
Discovery of (2S,4R)-1-(2-Aminoacetyl)-4-benzamidopyrrolidine-2-carboxylic Acid Hydrochloride (GAP-134)13, an Orally Active Small Molecule Gap-Junction Modifier for the Treatment of Atrial Fibrillation
John A. Butera et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
The Gap Junction Modifier, GAP-134 [(2S,4R)-1-(2-Aminoacetyl)-4-benzamido-pyrrolidine-2-carboxylic Acid], Improves Conduction and Reduces Atrial Fibrillation/Flutter in the Canine Sterile Pericarditis Model
Eric I. Rossman et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Cardioprotection Nitric Oxide, Protein Kinases, and Mitochondria
Gerd Heusch et al.
CIRCULATION (2008)
Local effects and mechanisms of antiarrhythmic peptide AAP10 in acute regional myocardial ischemia: electrophysiological and molecular findings
Joanna Jozwiak et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2008)
Effect of cyclosporine on reperfusion injury in acute myocardial infarction
Christophe Piot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Connexin 43 in ischemic pre- and postconditioning
Rainer Schulz et al.
HEART FAILURE REVIEWS (2007)
Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning
Peter Ferdinandy et al.
PHARMACOLOGICAL REVIEWS (2007)
Pharmacological modulation of gap junction function with the novel compound rotigaptide: A promising new principle for prevention of arrhythmias
Anne Louise Kjolbye et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2007)
Mechanisms of disease: Myocardial reperfusion injury
Derek M. Yellon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Hemichannels in cardiomyocytes open transiently during ischemia and contribute to reperfusion injury following brief ischemia
Kaori Shintani-Ishida et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Bidirectional role of tumor necrosis factor-α in coronary microembolization -: Progressive contractile dysfunction versus delayed protection against infarction
Andreas Skyschally et al.
CIRCULATION RESEARCH (2007)
No loss of cardioprotection by postconditioning in connexin 43-deficient mice
G Heusch et al.
BASIC RESEARCH IN CARDIOLOGY (2006)
Rotigaptide (ZP123) improves atrial conduction slowing in chronic volume overload-induced dilated atria
Ketil Haugan et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2006)
Identification of ischemia-regulated phosphorylation sites in connexin43: A possible target for the antiarrhythmic peptide analogue rotigaptide (ZP123)
Lene N. Axelsen et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2006)
Nitric oxide is a preconditioning mimetic and cardioprotectant and is the basis of many available infarct-sparing strategies
Michael V. Cohen et al.
CARDIOVASCULAR RESEARCH (2006)
Rotigaptide (ZP123) prevents spontaneous ventricular arrhythmias and reduces infarct size during myocardial ischemia/reperfusion injury in open-chest dogs
JK Hennan et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
The antiarrhythmic peptide rotigaptide (ZP123) increases gap junction intercellular communication in cardiac myocytes and HeLa cells expressing connexin 43
TC Clarke et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Treatment with the gap junction modifier rotigaptide (ZP123) reduces infarct size in rats with chronic myocardial infarction
K Haugan et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2006)
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
Douglas P. Zipes et al.
EUROPACE (2006)
Pharmacological preconditioning with tumor necrosis factor-α activates signal transducer and activator of transcription-3 at reperfusion without involving classic prosurvival kinases (Akt and extracellular signal-regulated kinase)
S Lecour et al.
CIRCULATION (2005)
Postconditioning the human heart
P Staat et al.
CIRCULATION (2005)
Impairment of diazoxide-induced formation of reactive oxygen species and loss of cardioprotection in Connexin 43 deficient mice
FR Heinzel et al.
CIRCULATION RESEARCH (2005)
Connexin 43 in cardiomyocyte mitochondria and its increase by ischemic preconditioning
K Boengler et al.
CARDIOVASCULAR RESEARCH (2005)
New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway
DJ Hausenloy et al.
CARDIOVASCULAR RESEARCH (2004)
Role of connexin 43 in ischemic preconditioning does not involve intercellular communication through gap junctions
X Li et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2004)
Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning
ZQ Zhao et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2003)
ZP123 increases gap junctional conductance and prevents Reentrant ventricular tachycardia during myocardial ischemia in open chest dogs
DZ Xing et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2003)
No ischemic preconditioning in heterozygous connexin43-deficient mice
U Schwanke et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2002)
Physiological role of gap-junctional hemichannels: Extracellular calcium-dependent isosmotic volume regulation
AP Quist et al.
JOURNAL OF CELL BIOLOGY (2000)
分享论文
